Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $87.59 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $48.00 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $26.99 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12.60 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $12.60 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($12.60) |
| 2021 | $14.80 | 1 | Janssen Biotech, Inc. ($14.80) |
| 2018 | $48.00 | 1 | Celgene Corporation ($48.00) |
| 2017 | $12.19 | 1 | Janssen Biotech, Inc. ($12.19) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Gastroenterology | ||||||
| 11/01/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Immunology | ||||||
| 12/14/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $48.00 | General |
| 01/13/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 135 | 135 | $153,320 | $19,440 |
| 2022 | 8 | 552 | 614 | $321,225 | $65,030 |
| 2021 | 10 | 746 | 918 | $403,195 | $109,660 |
| 2020 | 12 | 779 | 915 | $414,605 | $101,195 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 39 | 39 | $50,700 | $8,396 | 16.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $57,600 | $6,039 | 10.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $33,775 | $2,548 | 7.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $11,245 | $2,457 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 313 | $57,995 | $28,302 | 48.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 55 | 55 | $71,500 | $11,613 | 16.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $82,800 | $7,439 | 9.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 77 | 78 | $75,270 | $6,274 | 8.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $14,500 | $5,093 | 35.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 16 | 16 | $12,665 | $3,105 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $4,430 | $2,211 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $2,065 | $992.57 | 48.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 312 | 480 | $90,160 | $51,864 | 57.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $25,230 | $11,768 | 46.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 52 | 52 | $67,600 | $11,431 | 16.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 80 | 80 | $96,000 | $10,119 | 10.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 81 | 83 | $80,095 | $7,188 | 9.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 30 | 30 | $18,900 | $6,061 | 32.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 42 | 42 | $7,980 | $3,599 | 45.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 21 | $5,445 | $2,986 | 54.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 12 | 12 | $7,860 | $2,430 | 30.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 31 | $3,925 | $2,214 | 56.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 229 | 352 | $79,200 | $30,246 | 38.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 130 | 136 | $40,800 | $15,381 | 37.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 118 | 118 | $34,220 | $13,148 | 38.4% |
About Dr. Harvey Guttmann, M.D
Dr. Harvey Guttmann, M.D is a Gastroenterology healthcare provider based in Rydal, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194772533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harvey Guttmann, M.D has received a total of $87.59 in payments from pharmaceutical and medical device companies, with $12.60 received in 2022. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($87.59).
As a Medicare-enrolled provider, Guttmann has provided services to 2,212 Medicare beneficiaries, totaling 2,582 services with total Medicare billing of $295,325. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Rydal, PA
- Active Since 05/30/2006
- Last Updated 01/11/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1194772533
Products in Payments
- STELARA (Biological) $26.99
- XIFAXAN (Drug) $12.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rydal
Dr. Stuart Lubinski, M.d, M.D
Gastroenterology — Payments: $14,743
Dr. Cesar Delatorre, M.d, M.D
Gastroenterology — Payments: $2,877
Dr. Daniel Ringold, M.d, M.D
Gastroenterology — Payments: $2,130
Dr. Julia Binder, Md, MD
Gastroenterology — Payments: $1,099
Christina Brown, M.d, M.D
Gastroenterology — Payments: $1,072
Dr. Eric Goosenberg, M.d, M.D
Gastroenterology — Payments: $971.79